Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Effect of Honey on Glucose and Insulin Concentrations in Obese Girls.

Farakla I, Koui E, Arditi J, Papageorgiou I, Bartzeliotou A, Papadopoulos GE, Mantzou A, Papathanasiou C, Dracopoulou M, Papastamataki M, Moutsatsou P, Papassotiriou I, Chrousos GP, Charmandari E.

Eur J Clin Invest. 2018 Oct 28:e13042. doi: 10.1111/eci.13042. [Epub ahead of print]

PMID:
30368796
2.

Research update for articles published in EJCI in 2016.

Adlbrecht C, Blanco-Verea A, Bouzas-Mosquera MC, Brion M, Burtscher M, Carbone F, Chang TT, Charmandari E, Chen JW, Correia-Costa L, Dullaart RPF, Eleftheriades M, Fernandez-Fernandez B, Goliasch G, Gremmel T, Groeneveld ME, Henrique A, Huelsmann M, Jung C, Lichtenauer M, Montecucco F, Nicolaides NC, Niessner A, Palmeira C, Pirklbauer M, Sanchez-Niño MD, Sotiriadis A, Sousa T, Sulzgruber P, van Beek AP, Veronese N, Winter MP, Yeung KK, Bouzas-Mosquera A.

Eur J Clin Invest. 2018 Oct;48(10):e13016. doi: 10.1111/eci.13016. Epub 2018 Sep 16. Review. No abstract available.

PMID:
30099749
3.

The effectiveness of a health promotion and stress-management intervention program in a sample of obese children and adolescents.

Emmanouil CC, Pervanidou P, Charmandari E, Darviri C, Chrousos GP.

Hormones (Athens). 2018 Sep;17(3):405-413. doi: 10.1007/s42000-018-0052-2. Epub 2018 Aug 11.

PMID:
30099726
4.

The effect of intrauterine growth on leukocyte telomere length at birth.

Stefa A, Lamprokostopoulou A, Briana DD, Kontogeorgou A, Papageorgiou I, Malamitsi-Puchner A, Tsitsilonis O, Gagos S, Charmandari E.

J Matern Fetal Neonatal Med. 2018 Jun 6:1-6. doi: 10.1080/14767058.2018.1479392. [Epub ahead of print]

PMID:
29779414
5.

HCV genetics and genotypes dictate future antiviral strategies.

Papageorgiou L, Vlachakis C, Dragoumani K, Raftopoulou S, Brouzas D, Nicolaides NC, Chrousos GP, Charmandari E, Megalooikonomou V, Vlachakis D.

J Mol Biochem. 2017;6:33-40. Epub 2017 Dec 10.

6.

Electronic registry for the management of childhood obesity in Greece.

Kassari P, Papaioannou P, Billiris A, Karanikas H, Eleftheriou S, Thireos E, Manios Y, Chrousos GP, Charmandari E.

Eur J Clin Invest. 2018 Mar;48(3). doi: 10.1111/eci.12887. Epub 2018 Feb 11.

PMID:
29327339
7.

Research update for articles published in EJCI in 2015.

Al-Daghri NM, Batzel JJ, Burgmann H, Carbone F, Charmandari E, Chrousos GP, Distelmaier K, Cvirn G, Dullaart RPF, Dumitrascu DL, Esteve-Pastor MA, Gervasini G, Goliasch G, Goswami N, Gruppen EG, Hernández-Mijares A, Kalantaridou SN, Krause R, Latini R, Makrigiannakis A, Marín F, Masson S, Montecucco F, Ndrepepa G, Nicolaides NC, Novelli D, Orasan OH, Qorbani M, Ratzinger F, Roessler A, Sabico S, Sciatti E, Stefanaki C, Stoner L, Tabatabaei-Malazy O, Tatar E, Toz H, Uslu A, Victor VM, Vizzardi E.

Eur J Clin Invest. 2017 Oct;47(10):775-788. doi: 10.1111/eci.12819. No abstract available.

PMID:
28960328
8.

Vitamin D predictors in polycystic ovary syndrome: a meta-analysis.

Bacopoulou F, Kolias E, Efthymiou V, Antonopoulos CN, Charmandari E.

Eur J Clin Invest. 2017 Oct;47(10):746-755. doi: 10.1111/eci.12800. Epub 2017 Sep 7. Review.

PMID:
28795765
9.

The Role of S-Palmitoylation of the Human Glucocorticoid Receptor (hGR) in Mediating the Nongenomic Glucocorticoid Actions.

Nicolaides NC, Kino T, Roberts ML, Katsantoni E, Sertedaki A, Moutsatsou P, Psarra AG, Chrousos GP, Charmandari E.

J Mol Biochem. 2017;6(1):3-12. Epub 2017 Apr 15.

10.

Novel insights into the molecular mechanisms underlying generalized glucocorticoid resistance and hypersensitivity syndromes.

Nicolaides NC, Charmandari E.

Hormones (Athens). 2017 Apr;16(2):124-138. doi: 10.14310/horm.2002.1728. Review.

11.

Stress-Related and Circadian Secretion and Target Tissue Actions of Glucocorticoids: Impact on Health.

Nicolaides NC, Charmandari E, Kino T, Chrousos GP.

Front Endocrinol (Lausanne). 2017 Apr 28;8:70. doi: 10.3389/fendo.2017.00070. eCollection 2017. Review.

12.

Psychological vulnerability to stress in carriers of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Kyritsi EM, Koltsida G, Farakla I, Papanikolaou A, Critselis E, Mantzou E, Zoumakis E, Kolaitis G, Chrousos GP, Charmandari E.

Hormones (Athens). 2017 Jan;16(1):42-53. doi: 10.14310/horm.2002.1718.

13.

Increased glucocorticoid receptor expression in sepsis is related to heat shock proteins, cytokines, and cortisol and is associated with increased mortality.

Vardas K, Ilia S, Sertedaki A, Charmandari E, Briassouli E, Goukos D, Apostolou K, Psarra K, Botoula E, Tsagarakis S, Magira E, Routsi C, Stratakis CA, Nanas S, Briassoulis G.

Intensive Care Med Exp. 2017 Dec;5(1):10. doi: 10.1186/s40635-017-0123-8. Epub 2017 Feb 21.

14.

Paediatric stress: from neuroendocrinology to contemporary disorders.

Stavrou S, Nicolaides NC, Critselis E, Darviri C, Charmandari E, Chrousos GP.

Eur J Clin Invest. 2017 Mar;47(3):262-269. doi: 10.1111/eci.12724. Epub 2017 Feb 3. Review.

PMID:
28074555
15.

The effectiveness of a stress-management intervention program in the management of overweight and obesity in childhood and adolescence.

Stavrou S, Nicolaides NC, Papageorgiou I, Papadopoulou P, Terzioglou E, Chrousos GP, Darviri C, Charmandari E.

J Mol Biochem. 2016;5(2):63-70. Epub 2016 Jul 31.

16.

Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion.

Sertedaki A, Markou A, Vlachakis D, Kossida S, Campanac E, Hoffman DA, Sierra ML, Xekouki P, Stratakis CA, Kaltsas G, Piaditis GP, Chrousos GP, Charmandari E.

Clin Endocrinol (Oxf). 2016 Dec;85(6):845-851. doi: 10.1111/cen.13132. Epub 2016 Jul 12.

17.

Recent advances in the molecular mechanisms causing primary generalized glucocorticoid resistance.

Nicolaides N, Lamprokostopoulou A, Sertedaki A, Charmandari E.

Hormones (Athens). 2016 Jan-Mar;15(1):23-34. doi: 10.14310/horm.2002.1660. Review.

18.

Sequencing analysis of the human glucocorticoid receptor (NR3C1) gene in multiple sclerosis patients.

Kassi E, Semaniakou A, Sertedaki A, Evangelopoulos ME, Kazazoglou T, Kominakis A, Sfagos C, Charmandari E, Chrousos GP, Moutsatsou P.

J Neurol Sci. 2016 Apr 15;363:165-9. doi: 10.1016/j.jns.2016.02.054. Epub 2016 Feb 23.

PMID:
27000245
19.

Structural Analysis on the Pathologic Mutant Glucocorticoid Receptor Ligand-Binding Domains.

Hurt DE, Suzuki S, Mayama T, Charmandari E, Kino T.

Mol Endocrinol. 2016 Feb;30(2):173-88. doi: 10.1210/me.2015-1177. Epub 2016 Jan 8.

20.

Misfolding Ectodomain Mutations of the Lutropin Receptor Increase Efficacy of Hormone Stimulation.

Charmandari E, Guan R, Zhang M, Silveira LG, Fan QR, Chrousos GP, Sertedaki AC, Latronico AC, Segaloff DL.

Mol Endocrinol. 2016 Jan;30(1):62-76. doi: 10.1210/me.2015-1205. Epub 2015 Nov 10. Erratum in: Endocrinology. 2017 Jul 1;158(7):2406.

21.

Functional characterization of the hGRαT556I causing Chrousos syndrome.

Nicolaides NC, Skyrla E, Vlachakis D, Psarra AM, Moutsatsou P, Sertedaki A, Kossida S, Charmandari E.

Eur J Clin Invest. 2016 Jan;46(1):42-9. doi: 10.1111/eci.12563. Epub 2015 Dec 15.

PMID:
26541474
22.

Transient generalized glucocorticoid hypersensitivity.

Nicolaides NC, Lamprokostopoulou A, Polyzos A, Kino T, Katsantoni E, Triantafyllou P, Christophoridis A, Katzos G, Dracopoulou M, Sertedaki A, Chrousos GP, Charmandari E.

Eur J Clin Invest. 2015 Dec;45(12):1306-15. doi: 10.1111/eci.12554. Epub 2015 Nov 20.

PMID:
26479047
23.

A novel mutation of the hGR gene causing Chrousos syndrome.

Nicolaides NC, Geer EB, Vlachakis D, Roberts ML, Psarra AM, Moutsatsou P, Sertedaki A, Kossida S, Charmandari E.

Eur J Clin Invest. 2015 Aug;45(8):782-91. doi: 10.1111/eci.12470. Epub 2015 Jul 14.

PMID:
26031419
24.

Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential Hypertension.

Markou A, Sertedaki A, Kaltsas G, Androulakis II, Marakaki C, Pappa T, Gouli A, Papanastasiou L, Fountoulakis S, Zacharoulis A, Karavidas A, Ragkou D, Charmandari E, Chrousos GP, Piaditis GP.

J Clin Endocrinol Metab. 2015 Aug;100(8):2857-64. doi: 10.1210/jc.2015-1268. Epub 2015 May 14.

PMID:
25974737
25.

Familial or Sporadic Adrenal Hypoplasia Syndromes.

Kyritsi EM, Sertedaki A, Charmandari E, Chrousos GP.

In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2018 Oct 22.

26.

Adrenal Insufficiency.

Nicolaides NC, Chrousos GP, Charmandari E.

In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2017 Oct 14.

27.

Primary Generalized Glucocorticoid Resistance or Chrousos Syndrome.

Nicolaides NC, Kino T, Chrousos G, Charmandari E.

In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2017 Sep 10.

28.

Chrousos syndrome: from molecular pathogenesis to therapeutic management.

Nicolaides NC, Charmandari E.

Eur J Clin Invest. 2015 May;45(5):504-14. doi: 10.1111/eci.12426. Epub 2015 Mar 23. Review.

PMID:
25715669
29.

Variation in absorption and half-life of hydrocortisone influence plasma cortisol concentrations.

Hindmarsh PC, Charmandari E.

Clin Endocrinol (Oxf). 2015 Apr;82(4):557-61. doi: 10.1111/cen.12653. Epub 2014 Dec 19.

PMID:
25369980
30.

Stress, the stress system and the role of glucocorticoids.

Nicolaides NC, Kyratzi E, Lamprokostopoulou A, Chrousos GP, Charmandari E.

Neuroimmunomodulation. 2015;22(1-2):6-19. doi: 10.1159/000362736. Epub 2014 Sep 12. Review.

PMID:
25227402
31.
32.

Circadian endocrine rhythms: the hypothalamic-pituitary-adrenal axis and its actions.

Nicolaides NC, Charmandari E, Chrousos GP, Kino T.

Ann N Y Acad Sci. 2014 May;1318:71-80. doi: 10.1111/nyas.12464. Review.

33.

Adrenal insufficiency.

Charmandari E, Nicolaides NC, Chrousos GP.

Lancet. 2014 Jun 21;383(9935):2152-67. doi: 10.1016/S0140-6736(13)61684-0. Epub 2014 Feb 4. Review.

PMID:
24503135
34.

A novel point mutation of the human glucocorticoid receptor gene causes primary generalized glucocorticoid resistance through impaired interaction with the LXXLL motif of the p160 coactivators: dissociation of the transactivating and transreppressive activities.

Nicolaides NC, Roberts ML, Kino T, Braatvedt G, Hurt DE, Katsantoni E, Sertedaki A, Chrousos GP, Charmandari E.

J Clin Endocrinol Metab. 2014 May;99(5):E902-7. doi: 10.1210/jc.2013-3005. Epub 2014 Jan 31.

35.

A novel point mutation in the DNA-binding domain (DBD) of the human glucocorticoid receptor causes primary generalized glucocorticoid resistance by disrupting the hydrophobic structure of its DBD.

Roberts ML, Kino T, Nicolaides NC, Hurt DE, Katsantoni E, Sertedaki A, Komianou F, Kassiou K, Chrousos GP, Charmandari E.

J Clin Endocrinol Metab. 2013 Apr;98(4):E790-5. doi: 10.1210/jc.2012-3549. Epub 2013 Feb 20.

36.

Primary generalized familial and sporadic glucocorticoid resistance (Chrousos syndrome) and hypersensitivity.

Charmandari E, Kino T, Chrousos GP.

Endocr Dev. 2013;24:67-85. doi: 10.1159/000342505. Epub 2013 Feb 1. Review.

37.

Stress response and child health.

Charmandari E, Achermann JC, Carel JC, Soder O, Chrousos GP.

Sci Signal. 2012 Oct 30;5(248):mr1. doi: 10.1126/scisignal.2003595. Review.

PMID:
23112343
38.

Primary generalized glucocorticoid resistance and hypersensitivity: the end-organ involvement in the stress response.

Charmandari E.

Sci Signal. 2012 Oct 2;5(244):pt5. doi: 10.1126/scisignal.2003337.

PMID:
23033539
39.

Deconvolution analysis of 24-h serum cortisol profiles informs the amount and distribution of hydrocortisone replacement therapy.

Peters CJ, Hill N, Dattani MT, Charmandari E, Matthews DR, Hindmarsh PC.

Clin Endocrinol (Oxf). 2013 Mar;78(3):347-51. doi: 10.1111/j.1365-2265.2012.04502.x.

PMID:
22803584
40.

A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension.

Charmandari E, Sertedaki A, Kino T, Merakou C, Hoffman DA, Hatch MM, Hurt DE, Lin L, Xekouki P, Stratakis CA, Chrousos GP.

J Clin Endocrinol Metab. 2012 Aug;97(8):E1532-9. doi: 10.1210/jc.2012-1334. Epub 2012 May 24.

41.

Glucocorticoid receptor: implications for rheumatic diseases.

Kino T, Charmandari E, Chrousos GP.

Clin Exp Rheumatol. 2011 Sep-Oct;29(5 Suppl 68):S32-41. Epub 2011 Oct 21. Review.

42.

Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man.

Charmandari E, Chrousos GP, Lambrou GI, Pavlaki A, Koide H, Ng SS, Kino T.

PLoS One. 2011;6(9):e25612. doi: 10.1371/journal.pone.0025612. Epub 2011 Sep 28.

43.

Primary generalized glucocorticoid resistance and hypersensitivity.

Charmandari E.

Horm Res Paediatr. 2011;76(3):145-55. doi: 10.1159/000330759. Epub 2011 Sep 6. Review.

44.

Plasma proteomic analysis in obese and overweight prepubertal children.

Galata Z, Moschonis G, Makridakis M, Dimitraki P, Nicolaides NC, Manios Y, Bartzeliotou A, Chrousos GP, Charmandari E.

Eur J Clin Invest. 2011 Dec;41(12):1275-83. doi: 10.1111/j.1365-2362.2011.02536.x. Epub 2011 May 16.

PMID:
21569026
45.

Chrousos syndrome: a seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signalling changes.

Charmandari E, Kino T.

Eur J Clin Invest. 2010 Oct;40(10):932-42. doi: 10.1111/j.1365-2362.2010.02336.x. Epub 2010 Aug 19. Review.

46.

The human glucocorticoid receptor: molecular basis of biologic function.

Nicolaides NC, Galata Z, Kino T, Chrousos GP, Charmandari E.

Steroids. 2010 Jan;75(1):1-12. doi: 10.1016/j.steroids.2009.09.002. Epub 2009 Oct 7. Review.

47.
48.

Evaluation of the hypothalamic-pituitary-adrenal axis function in childhood and adolescence.

Chrousos GP, Kino T, Charmandari E.

Neuroimmunomodulation. 2009;16(5):272-83. doi: 10.1159/000216185. Epub 2009 Jun 29. Review.

49.

A novel point mutation in the amino terminal domain of the human glucocorticoid receptor (hGR) gene enhancing hGR-mediated gene expression.

Charmandari E, Ichijo T, Jubiz W, Baid S, Zachman K, Chrousos GP, Kino T.

J Clin Endocrinol Metab. 2008 Dec;93(12):4963-8. doi: 10.1210/jc.2008-0892. Epub 2008 Sep 30.

50.

Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder.

Charmandari E, Kino T, Ichijo T, Chrousos GP.

J Clin Endocrinol Metab. 2008 May;93(5):1563-72. doi: 10.1210/jc.2008-0040. Epub 2008 Mar 4. Review.

Supplemental Content

Loading ...
Support Center